Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Individualized High Dose Methotrexate in Pediatric Cancer
NCT02076997Phase 1Completed
- Sponsor
- Baylor College of Medicine
- Start
- Jan 2014
- Primary completion
- May 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of methotrexate in cancer, sponsored by Baylor College of Medicine. Primary endpoint: Incidence of Success (Achieving an End Infusion Peripheral Blood Methotrexate Concentration Between 50-80 μM) at 1 month. Started Jan 2014; status: completed.
02
Drugs
methotrexate
03
Conditions
cancer
Beyond the preview
Go deeper on NCT02076997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02076997.